Pettinga Financial Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$302K Hold
833
0.05% 119
2026
Q1
$293K Hold
833
0.06% 121
2025
Q4
$273K Hold
833
0.05% 121
2025
Q3
$235K Hold
833
0.05% 124
2025
Q2
$233K Hold
833
0.05% 119
2025
Q1
$260K Sell
833
-70
-8% -$20.7K 0.06% 110
2024
Q4
$235K Hold
903
0.05% 115
2024
Q3
$291K Sell
903
-25
-3% -$8.18K 0.07% 101
2024
Q2
$290K Sell
928
-25
-3% -$7.34K 0.07% 103
2024
Q1
$271K Hold
953
0.07% 103
2023
Q4
$274K Buy
953
+150
+19% +$40.9K 0.07% 103
2023
Q3
$216K Buy
+803
New +$200K 0.07% 101
2023
Q1
Sell
-803
Closed -$211K 100
2022
Q4
$211K Buy
+803
New +$215K 0.07% 94
2022
Q2
Sell
-828
Closed -$200K 104
2022
Q1
$200K Buy
+828
New +$190K 0.05% 103
2021
Q2
Sell
-807
Closed -$201K 110
2021
Q1
$201K Buy
+807
New +$193K 0.06% 96
2020
Q4
Sell
-807
Closed -$205K 91
2020
Q3
$205K Buy
+807
New +$200K 0.09% 76

Other funds holding AMGN

Pettinga Financial Advisors's AMGN Position: Q2 2026 in Review

Pettinga Financial Advisors held its Amgen (AMGN) position steady in Q2 2026 at 833 shares worth $302K. The position accounts for 0.05% of the portfolio, ranked #119.

Pettinga Financial Advisors first reported a position in AMGN in Q3 2020 and has held it in 16 quarters since. 3,146 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Pettinga Financial Advisors held 833 shares of Amgen worth $302K as of Q2 2026.
  • Pettinga Financial Advisors left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.05% of Pettinga Financial Advisors's portfolio in Q2 2026, its #119 holding.
  • Pettinga Financial Advisors first reported a position in Amgen in Q3 2020 and has held it in 16 quarters since.
  • 3,146 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Pettinga Financial Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.